Literature DB >> 8210327

Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model.

R van Os1, H D Thames, A W Konings, J D Down.   

Abstract

Fractionated and low-dose-rate total-body irradiation (TBI) were compared with single-dose high-dose-rate TBI for induction of long-term hemopoietic chimerism in a murine syngeneic bone marrow transplantation model. At 5 months after TBI and bone marrow transplantation, the degree of stable blood chimerism was determined from the proportion of stem cell-derived donor (B6-Gpi-1a) and host (B6-Gpi-1b) blood erythrocytes. This end point was used to construct radiation dose-response curves for long-term donor marrow engraftment corresponding to ablation of primitive bone marrow stem cells of the host. Increasing dose fractionation and decreasing dose rate had the effect of restoring host hemopoiesis and required higher TBI doses for equal donor engraftment. Most of the dose recovery occurred within the first 6 h between fractions, consistent with the kinetics of sublethal damage repair. The late chimerism data were fitted to the linear-quadratic model using indirect and direct analysis for a fixed threshold response. Both analyses gave relatively low alpha/beta ratios (below 2 Gy), within the range normally seen in late-responding tissues. The dose-rate data gave a repair half-time of 2 h as estimated by the incomplete-repair model. These estimates contrast with the much higher alpha/beta values and lower repair half-times derived from acute hemopoietic failure as indicated by LD50/30, with the implication that separate target cell populations with differing radiosensitivities are involved in these two bone marrow end points.

Entities:  

Mesh:

Year:  1993        PMID: 8210327

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Effects of proton radiation dose, dose rate and dose fractionation on hematopoietic cells in mice.

Authors:  J H Ware; J Sanzari; S Avery; C Sayers; G Krigsfeld; M Nuth; X S Wan; A Rusek; A R Kennedy
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

2.  Radiation Dose-Rate Effects on Gene Expression in a Mouse Biodosimetry Model.

Authors:  Sunirmal Paul; Lubomir B Smilenov; Carl D Elliston; Sally A Amundson
Journal:  Radiat Res       Date:  2015-06-26       Impact factor: 2.841

3.  Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice.

Authors:  Imranul Alam; Rita L Gerard-O'Riley; Dena Acton; Sara L Hardman; Madeline Murphy; Marta B Alvarez; Rachel J Blosser; Anthony Sinn; Edward F Srour; Melissa A Kacena; Michael J Econs
Journal:  FASEB J       Date:  2022-09       Impact factor: 5.834

Review 4.  Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies.

Authors:  Raimon Duran-Struuck; Robert C Dysko
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-01       Impact factor: 1.232

5.  A model of photon cell killing based on the spatio-temporal clustering of DNA damage in higher order chromatin structures.

Authors:  Lisa Herr; Thomas Friedrich; Marco Durante; Michael Scholz
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

6.  Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.

Authors:  Johnnie J Orozco; Ethan R Balkin; Ted A Gooley; Aimee Kenoyer; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Mark D Hylarides; Mazyar Shadman; Damian J Green; Ajay K Gopal; Oliver W Press; John M Pagel
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

7.  Development of an experimental model for radiation-induced inhibition of cranial bone regeneration.

Authors:  Hong-Moon Jung; Jeong-Eun Lee; Seoung-Jun Lee; Jung-Tae Lee; Tae-Yub Kwon; Tae-Geon Kwon
Journal:  Maxillofac Plast Reconstr Surg       Date:  2018-11-22

8.  Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.

Authors:  Y Belkacémi; F Pène; E Touboul; B Rio; V Leblond; N C Gorin; A Laugier; C Gemici; M Housset; M Ozsahin
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.